menu
    • menu

    Company profile for Abivax

    NEW Drugs in Dev: 4
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abivax is mobilizing the body’s natural immune system machinery to treat patients with inflammatory diseases, viral infections and cancer.As a clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to optimize and develop drug candidates to treat ulcerative colitis and other inflammatory diseases (ABX464), HIV (ABX464), and liver cancer (ABX196). Our mission is to utilize Abivax’s drug develo...
    Abivax is mobilizing the body’s natural immune system machinery to treat patients with inflammatory diseases, viral infections and cancer.As a clinical-stage company, Abivax leverages its immune enhancing and antiviral platforms to optimize and develop drug candidates to treat ulcerative colitis and other inflammatory diseases (ABX464), HIV (ABX464), and liver cancer (ABX196). Our mission is to utilize Abivax’s drug development platforms to bring innovative and effective solutions to patients in these therapeutic areas with significant unmet needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AbivaxFrance Flag
    Country
    Country
    France
    Address
    Address
    5, rue de la Baume 75008 Paris
    Telephone
    Telephone
    +33 (0) 1 53 83 08 41
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.abivax.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abivax/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ABIVAX_

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abivax Stock Falls as Cancer Cases Ulcerative Colitis Ph 3 Win
    Abivax Stock Falls as Cancer Cases Ulcerative Colitis Ph 3 Win

    02 Jun 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/abivax-stock-crashes-cancer-cases-overshadow-stellar-efficacy-ulcerative-colitis-phase-3

    FIERCE BIOTECH
    02 Jun 2026
    Share Share
    Abivax Reports Phase 3 ABTECT Trial Results For Obefazimod
    Abivax Reports Phase 3 ABTECT Trial Results For Obefazimod

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304711/0/en/abivax-announces-landmark-phase-3-abtect-maintenance-trial-results-evaluating-obefazimod-in-moderately-to-severely-active-ulcerative-colitis.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Abivax Reports Q1 2026 Results and 3-Year Obefazimod OLE Data
    Abivax Reports Q1 2026 Results and 3-Year Obefazimod OLE Data

    22 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/22/3300344/0/en/abivax-presents-first-quarter-2026-financial-results-and-reports-three-year-interim-data-from-study-108-a-phase-2a-2b-open-label-extension-trial-of-obefazimod-following-dose-de-esc.html

    GLOBENEWSWIRE
    22 May 2026
    Share Share
    Abivax Reports May 2026 Annual General Meeting Outcomes
    Abivax Reports May 2026 Annual General Meeting Outcomes

    11 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/11/3292317/0/en/abivax-announces-results-of-its-may-11-2026-annual-general-meeting.html

    GLOBENEWSWIRE
    11 May 2026
    Share Share
    Abivax To Present Data On Obefazimod At Digestive Disease Week
    Abivax To Present Data On Obefazimod At Digestive Disease Week

    22 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/22/3279387/0/en/abivax-to-present-data-on-obefazimod-at-digestive-disease-week.html

    GLOBENEWSWIRE
    22 Apr 2026
    Share Share
    Abivax Annual Ordinary & Extraordinary General Meeting of May 11
    Abivax Annual Ordinary & Extraordinary General Meeting of May 11

    20 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7190399

    FIRSTWORD PHARMA
    20 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search